Location: Drammen
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Drammen
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) Phase 3 · Drammen Sykehus, Vestre Viken HF ( Site 2001) · Merck Sharp & Dohme LLC · NCT06393374 Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or B NA · Vestre Viken Health Trust · Vestre Viken Hospital Trust · NCT06197048 A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study NA · Vestre Viken HF · Haukeland University Hospital · NCT05095571 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS Phase 3 · Drammen Sykehus, Vestre Viken HF · Eli Lilly and Company · NCT06890598 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit Phase 3 · Drammen Sykehus, Vestre Viken HF ( Site 1903) · Merck Sharp & Dohme LLC · NCT06077760 A Talus Implant in Patients Between 20-60 Years of Age Followed up for a Minimum of 2 Years After Surgery NA · Drammen Sykehus · Vestre Viken Hospital Trust · NCT06932380 Management of Patients With Heart Failure at Home After Hospital Discharge NA · Drammen Hospital, Vestre Viken HF · University Hospital, Akershus · NCT06576752 Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial Phase 4 · Drammen Hospital · Oslo University Hospital · NCT06653634 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR Phase 3 · Drammen Sykehus, Vestre Viken HF · Eli Lilly and Company · NCT06119581 Strengthening Hope After ICU Discharge NA · Vestre Viken HF, Bærum Hospital · Oslo University Hospital · NCT06569901 Comparing Enhanced Cognitive-behavior Therapy and Family-based Treatment for Adolescents With an Eating Disorder NA · Vestre Viken Health Trust · Oslo University Hospital · NCT06256380 Wrist and Carpal Arthrodeses. A 1-year Follow-up Study. Phase N/A · Drammen Sykehus · Vestre Viken Hospital Trust · NCT06917235 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina Phase 2/Phase 3 · Local Institution - 007-310 · Mirati Therapeutics Inc. · NCT04613596 Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer Phase 3 · Vestre Viken Hospital Trust · Sven Löffeler · NCT05448547 Improving Public Cancer Care by Implementing Precision Medicine in Norway Phase 2 · Vestre Viken Hospital · Oslo University Hospital · NCT04817956 A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Parti Phase 3 · Drammen Sykehus, Vestre Viken HF ( Site 2502) · Merck Sharp & Dohme LLC · NCT06312137 Positive Feeding of the Preterm Infant NA · Vestre Viken Hospital Trust · Oslo Metropolitan University · NCT06189352 The Norwegian Antirheumatic Drug Register Phase N/A · Vestre Viken HF Drammen Hospital · Diakonhjemmet Hospital · NCT01581294 The Norwegian Immunotherapy in Multiple Myeloma Study Phase N/A · Drammen hospital · St. Olavs Hospital · NCT06855121 A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Phase 2/Phase 3 · Local Institution - 0096 · Bristol-Myers Squibb · NCT07063745 A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) Phase 3 · Drammen Sykehus, Vestre Viken HF ( Site 3700) · Merck Sharp & Dohme LLC · NCT06966700 INTEgRated Health CARE for Patients With Frailty and Heart Failure NA · Drammen Hospital · Vestre Viken Hospital Trust · NCT06444321 Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer Phase 2 · Vestre Viken Health Trust · Vestre Viken Hospital Trust · NCT05344209 Cognitive Behavioural Therapy for Insomnia in Patients With Coronary Heart Disease NA · Vestre Viken Trust Drammen hospital · Vestre Viken Hospital Trust · NCT06749951 Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cel Phase 3 · Seksjon for kreftbehandling, Drammen Hospital · Gilead Sciences · NCT06801834 Biology of Juvenile Myoclonic Epilepsy Phase N/A · Vestre Viken Health Trust, Oslo · King's College London · NCT03400371 D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression Phase 2 · Vestre Viken Hospital · Haukeland University Hospital · NCT07312110 Health-Related Quality of Life in Children and Adolescents With Clubfoot Phase N/A · Vestreviken · Vestre Viken Hospital Trust · NCT06906406 Exercise Training Study of Patients With Claudicatio Intermittens NA · Vestre Viken, Drammen sykehus · Norwegian University of Science and Technology · NCT06448390 Antibiotic Therapy in Viral Airway Infections Phase 4 · Drammen Hospital, Vestre Viken Hospital Trust · University Hospital, Akershus · NCT05045612
Look up another city
Look up another condition